Matthew Gline
2022
In 2022, Matthew Gline earned a total compensation of $49M as Chief Executive Officer at Roivant Sciences Ltd., a 61% increase compared to previous year.
Compensation breakdown
| Bonus | $1,036,750 |
|---|---|
| Option Awards | $47,206,737 |
| Salary | $725,000 |
| Other | $10,339 |
| Total | $48,978,825 |
Gline received $47.2M in option awards, accounting for 96% of the total pay in 2022.
Gline also received $1M in bonus, $725K in salary and $10.3K in other compensation.
Rankings
In 2022, Matthew Gline's compensation ranked 12th out of 5,418 executives tracked by ExecPay. In other words, Gline earned more than 99.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12 out of 5,418 | 100th |
Division Manufacturing | 4 out of 2,943 | 100th |
Major group Chemicals And Allied Products | 1 out of 1,314 | 100th |
Industry group Drugs | 1 out of 1,219 | 100th |
Industry Pharmaceutical Preparations | 1 out of 876 | 100th |
Source: SEC filing on July 31, 2023.
Gline's colleagues
We found two more compensation records of executives who worked with Matthew Gline at Roivant Sciences Ltd. in 2022.